Arrhythmia suppression in postmyocardial infarction patients with special notation to cardiac arrhythmia suppression trial

Affiliations

Review

M Gheorghiade et al. Prog Cardiovasc Dis. 1991 Jan-Feb.

. 1991 Jan-Feb;33(4):213-8.

doi: 10.1016/0033-0620(91)90026-i.

No abstract available

Similar articles

Clinical trials of antiarrhythmic drugs in postmyocardial infarction and congestive heart failure patients.
Camm AJ, Yap YG. Camm AJ, et al. J Cardiovasc Pharmacol Ther. 2001 Jan;6(1):99-106. doi: 10.1177/107424840100600110. J Cardiovasc Pharmacol Ther. 2001. PMID: 11452341 Review. No abstract available.
[Cardiac Arrhythmia Suppression Trial: a disappointment?].
Magalhães CO. Magalhães CO. Arq Bras Cardiol. 1990 Sep;55(3):153-4. Arq Bras Cardiol. 1990. PMID: 2095719 Portuguese. No abstract available.
[Anti-arrhythmia agents following a myocardial infarct: the results of the CAST study. Cardiac Arrhythmia Suppression Trial].
Hohnloser S. Hohnloser S. Dtsch Med Wochenschr. 1991 Jul 26;116(30):1166-7. Dtsch Med Wochenschr. 1991. PMID: 1855450 Clinical Trial. German. No abstract available.
An interim perspective on the removal of encainide and flecainide from the cardiac arrhythmia suppression trial.
Coyle JD, Schaal SF. Coyle JD, et al. DICP. 1989 Jun;23(6):478-9. doi: 10.1177/106002808902300609. DICP. 1989. PMID: 2500783 Clinical Trial. No abstract available.
Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
Gambhir DS. Gambhir DS. Indian Heart J. 1996 Jul-Aug;48(4):339-41. Indian Heart J. 1996. PMID: 8908817 Review. No abstract available.